Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,332 | -24,384 | -1,629 | -1,225 | -1,017 |
| Depreciation Amortization | 1 | 61 | 43 | 23 | 2 |
| Accounts receivable | -36 | 98 | -73 | -52 | -26 |
| Other Working Capital | -229 | -391 | 218 | -52 | -141 |
| Other Operating Activity | 101 | 23,027 | 965 | 882 | 915 |
| Operating Cash Flow | $-1,495 | $-1,589 | $-475 | $-425 | $-266 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1 | -1 | -1 | -1 |
| Investing Cash Flow | $N/A | $-1 | $-1 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 200 | 200 | 200 | 100 |
| Common Stock Issued | 2,914 | 18,649 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -71 | -53 | -35 |
| Financing Cash Flow | $2,914 | $18,849 | $129 | $147 | $65 |
| Exchange Rate Effect | -3 | -5 | -6 | -3 | -8 |
| Beginning Cash Position | 17,645 | 391 | 391 | 391 | 391 |
| End Cash Position | 19,061 | 17,645 | 38 | 111 | 181 |
| Net Cash Flow | $1,416 | $17,253 | $-353 | $-281 | $-210 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,495 | -1,589 | -475 | -425 | -266 |
| Capital Expenditure | N/A | -1 | -1 | -1 | -1 |
| Free Cash Flow | -1,495 | -1,590 | -476 | -425 | -267 |